Vivos Therapeutics Inc. (VVOS) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Vivos Therapeutics Inc.

    NASDAQ: VVOS · Real-Time Price · USD
    3.12
    -0.23 (-6.87%)
    At close: Sep 26, 2025, 3:59 PM
    3.20
    2.56%
    After-hours: Sep 26, 2025, 07:48 PM EDT

    Vivos Therapeutics Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 6.26M 1.64M 3.52M 24.03M
    Short-Term Investments
    		 n/a n/a n/a n/a
    Long-Term Investments
    		 n/a n/a n/a n/a
    Other Long-Term Assets
    		 216K 307K 374K 356K
    Receivables
    		 430K 202K 457K 1.72M
    Inventory
    		 n/a n/a n/a n/a
    Other Current Assets
    		 783K n/a 1.45M n/a
    Total Current Assets
    		 7.47M 2.46M 5.42M 27.32M
    Property-Plant & Equipment
    		 4.38M 4.7M 4.78M 2.83M
    Goodwill & Intangibles
    		 3.21M 3.26M 3.15M 3.18M
    Total Long-Term Assets
    		 7.81M 8.27M 8.3M 6.37M
    Total Assets
    		 15.28M 10.73M 13.72M 33.69M
    Account Payables
    		 1.1M 2.15M 1.41M 920K
    Deferred Revenue
    		 896K 2.14M 2.93M 2.4M
    Short-Term Debt
    		 477K 474K 419K 1.26M
    Other Current Liabilities
    		 277K 560K 280K 1.46M
    Total Current Liabilities
    		 4.98M 7.29M 6.81M 7.51M
    Long-Term Debt
    		 n/a n/a n/a 298K
    Other Long-Term Liabilities
    		 1.22M 1.22M 112K 641K
    Total Long-Term Liabilities
    		 2.35M 3.03M 2.11M 641K
    Total Liabilities
    		 7.33M 10.32M 8.92M 8.15M
    Total Debt
    		 1.51M 2M 2.41M 1.63M
    Book Value
    		 7.95M 411K 4.8M 25.54M
    Book Value Per Share
    		 1.58 0.34 5.22 30.07
    Common Stock
    		 n/a n/a 2K 2K
    Retained Earnings
    		 -104.19M -93.05M -79.47M -55.62M
    Comprehensive Income
    		 n/a n/a n/a n/a
    Shareholders Equity
    		 7.95M 411K 4.8M 25.54M
    Total Investments
    		 n/a n/a n/a n/a

    Add to Watchlist